Sign inJoin
Company / Finance

McKesson Corporation

MCK · NYSE

McKesson reported FY2026 revenue of $403.4 billion and FY2026 operating income of $6.2 billion. The thesis depends on pharma distribution scale, specialty growth, working capital, margins and cash conversion.

FollowAdd to WatchlistAsk Question
NYSEMCKCoverage BootstrapMcKesson Corporation
Latest ReportMay 20, 2026MCK: McKesson scale needs distribution margins to keep turning into cashView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 company reports
Latest Thesis

MCK: McKesson scale needs distribution margins to keep turning into cash

McKesson reported FY2026 revenue of $403.4 billion and FY2026 operating income of $6.2 billion. The thesis depends on pharma distribution scale, specialty growth, working capital, margins and cash conversion.

May 20, 2026Research reportSlides available
Read reportOpen slidesDiscussion (0)
McKesson CorporationMcKesson scale needs distribution margins to keep turning into cMay 20, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
MCK: McKesson scale needs distribution margins to keep turning into cashMcKesson reported FY2026 revenue of $403.4 billion and FY2026 operating income of $6.2 billion. The thesis depends on pharma distribution scale, specialty growth, working capital, margins and cash conversion.NYSEMay 20, 2026Research reportReadSlides